InvestorsHub Logo

ExtremelyBullishZig

12/21/22 3:14 PM

#393907 RE: jav0033 #393904

Up until the last presentation of the year...catalysts will still be listed as EOY... which means the word liar gets to be applied to Missling yet again. Because he knows that they cannot possibly happen...yet still maintains the position that they will.

Gator328

12/21/22 3:35 PM

#393913 RE: jav0033 #393904

If I were Dr. Missling I wouldn't want to release any more information to the public either. It has to be so excruciatingly frustrating for him to have to watch the internet erupt with claims that he's a liar and scammer while message board posters twist his words into something completely different like a bad game of middle school "telephone."

If the stock price is going to be hammered every time he speaks no matter what he says, why speak much at all? Eventually he'll get to speak to the FDA and that's the only audience he cares about.

The good news is that if Blarcaamesine is approved, the free market will have several options for physicians to prescribe and let the best drug win. Cash flows will determine the stock price, and Dr. Missling can move into the role he is much better equipped to play: the CEO of a profitable company in growth mode. This is where his Kellogg MBA is going to be put to good use and it's during this time the stock will show its greatest gains. Most of us will have moved on by then.

bas2020

12/22/22 12:15 AM

#393985 RE: jav0033 #393904

No worries. Perhaps they are now focused on extremely positive P3 AD results and getting the additional data released and submitted to regulatory authorities. This will be the surest way to approval in 2023. The other indications are just icing on the cake.